retatrutide clinical trial fat loss Subcutaneous Results: What Trials Reveal About Effectiveness and Safety What the clinical trials say

Comprehensive Evaluation: We assess metabolic rate, hormone balance, medical history, and lifestyle factors to design a custom plan

Storing vials in clear glass under ambient light reduces potency by up to 40% within 48 hours

Age and chronodisruption in mouse heart: Effect of the NLRP3 inflammasome and melatonin therapy

News provided by Novo Nordisk May 01, 2026, 08:04 ET With an updated formulation of semaglutide tablets and new branding, Ozempic will be available in a pill Ozempic (semaglutide) pill is the only oral GLP-1 medicine approved for both primary and secondary cardiovascular risk reduction of heart attack, stroke, and death in adults with type 2 diabetes at high risk for these events, including those with known heart disease 1 Ozempic pill will be covered by insurance for most patients with type 2 diabetes for as little as $25 and available via self-pay through NovoCare Pharmacy and major telehealth providers PLAINSBORO, N.J., May 1, 2026 /PRNewswire/ -- Novo Nordisk announced that starting Monday, May 4, Ozempic (semaglutide) tablets 1.5 mg, 4 mg, and 9 mg will be available for adults with type 2 diabetes in the US